| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | Chief Financial Officer | Ordinary Shares with a nominal value of GBP0.001 per share | 0 | $0 | $0.06 | Sep 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | Sep 2, 2025 | 1 | -$950 | 4 | Sep 3, 2025 | Chief Financial Officer |
| ADAP | Adaptimmune Therapeutics PLC | Jan 15, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Chief Financial Officer |
| ADAP | Adaptimmune Therapeutics PLC | Jan 17, 2023 | 3 | $0 | 4 | Jan 17, 2023 | Chief Financial Officer |
| ADAP | Adaptimmune Therapeutics PLC | May 20, 2022 | 1 | $11.3K | 4 | May 23, 2022 | Chief Financial Officer |
| ADAP | Adaptimmune Therapeutics PLC | Jan 12, 2022 | 2 | $0 | 4 | Jan 13, 2022 | Chief Financial Officer |